A new survey from the nonprofit research group found that many Americans are increasingly worried about the cost of living, but fears over how to pay for medical insurance premiums, drug costs and copays are afflicting a supermajority (66%).

Heated tension between state and federal AI regulators is coming, predict two attorneys subspecialized in AI startup success, data privacy and cybersecurity.

The Biograph One is the company's second-generation PET/MRI combo scanner—its first in 14 years.

A growing chorus of academic physicians, policy experts and public health specialists is harmonizing behind the idea of licensing medical GenAI models like they’re doctors or nurses.

The federal government recently released new data pertaining to the landmark legislation, meant to protect patients from receiving unexpected medical bills. 

If all American voters were single-issue deciders and the cost of healthcare were their issue, Democrat candidates would win the mid-term elections handily. But loyalists of the donkey party shouldn’t be smug around their elephant counterparts. 

The program creates a network of accredited sites where radiation oncologists can complete the final regulatory requirements needed to become authorized users for RPT.

Both recalls are categorized as Class 2, which the FDA designates for issues that have the potential to “cause temporary or medically reversible adverse health consequences."